(Q36897642)

16 August 2017

Matrix metalloproteinase expression in an experimentally-induced DTH model of multiple sclerosis in the rat CNS. (English)

1 reference

16 August 2017

0 references

Anthony DC

1

1 reference

16 August 2017

Miller KM

2

1 reference

16 August 2017

Fearn S

3

1 reference

16 August 2017

Townsend MJ

4

1 reference

16 August 2017

Opdenakker G

5

1 reference

16 August 2017

Wells GM

6

1 reference

16 August 2017

Clements JM

7

1 reference

16 August 2017

Chandler S

8

1 reference

16 August 2017

Gearing AJ

9

1 reference

16 August 2017

Perry VH

10

1 reference

16 August 2017

1 July 1998

1 reference

Journal of Neuroimmunology

16 August 2017

1 reference

16 August 2017

87

1 reference

16 August 2017

1-2

1 reference

16 August 2017

62-72

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2898%2900046-0

16 August 2017

1 reference

7 January 2021

MS: a localized immune disease of the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2898%2900046-0

7 January 2021

Purification of rabbit bone inhibitor of collagenase

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2898%2900046-0

7 January 2021

Matrix metalloproteinases degrade myelin basic protein

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2898%2900046-0

7 January 2021

Matrix metalloproteinase expression during experimental autoimmune encephalomyelitis and effects of a combined matrix metalloproteinase and tumour necrosis factor-alpha inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2898%2900046-0

7 January 2021

The Expression of Tissue-type Plasminogen Activator, Matrix Metalloproteases and Endogenous Inhibitors in the Central Nervous System in Multiple Sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2898%2900046-0

7 January 2021

The roles of host and donor cells in the rejection of skin allografts by T cell-deprived rats injected with syngeneic T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2898%2900046-0

7 January 2021

Processing of tumour necrosis factor-α precursor by metalloproteinases

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2898%2900046-0

7 January 2021

Matrix metalloproteinases and processing of pro-TNF-alpha.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2898%2900046-0

7 January 2021

Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2898%2900046-0

7 January 2021

Matrilysin is expressed by lipid-laden macrophages at sites of potential rupture in atherosclerotic lesions and localizes to areas of versican deposition, a proteoglycan substrate for the enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2898%2900046-0

7 January 2021

Suppression of experimental allergic encephalomyelitis in the Lewis rat by the matrix metalloproteinase inhibitor Ro31-9790

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2898%2900046-0

7 January 2021

Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2898%2900046-0

7 January 2021

Interferon beta-1b inhibits gelatinase secretion and in vitro migration of human T cells: a possible mechanism for treatment efficacy in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2898%2900046-0

7 January 2021

Matrix metalloproteinases in the normal human central nervous system, microglial nodules, and multiple sclerosis lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2898%2900046-0

7 January 2021

The matrix-degrading metalloproteinases

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2898%2900046-0

7 January 2021

Demyelination in the central nervous system following a delayed-type hypersensitivity response to bacillus Calmette-Guérin

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2898%2900046-0

7 January 2021

Delayed-type hypersensitivity lesions in the central nervous system are prevented by inhibitors of matrix metalloproteinases.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2898%2900046-0

7 January 2021

Ultrastructural studies of an immune-mediated inflammatory response in the CNS parenchyma directed against a non-CNS antigen.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2898%2900046-0

7 January 2021

Stromelysin is an activator of procollagenase. A study with natural and recombinant enzymes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2898%2900046-0

7 January 2021

Matrix metalloproteinase degradation of elastin, type IV collagen and proteoglycan. A quantitative comparison of the activities of 95 kDa and 72 kDa gelatinases, stromelysins-1 and -2 and punctuated metalloproteinase (PUMP).

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2898%2900046-0

7 January 2021

Evidence for dendritic competition in the developing retina

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2898%2900046-0

7 January 2021

Leukocyte Gelatinase B Cleavage Releases Encephalitogens from Human Myelin Basic Protein

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2898%2900046-0

7 January 2021

The induction of 72-kD gelatinase in T cells upon adhesion to endothelial cells is VCAM-1 dependent

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2898%2900046-0

7 January 2021

Matrix metalloproteinases in brain injury

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2898%2900046-0

7 January 2021

Tumor necrosis factor-alpha-induced gelatinase B causes delayed opening of the blood-brain barrier: an expanded therapeutic window

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2898%2900046-0

7 January 2021

Brain extracellular matrix

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2898%2900046-0

7 January 2021

Characterization of MRI response to treatment with interferon beta-1b: contrast-enhancing MRI lesion frequency as a primary outcome measure.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2898%2900046-0

7 January 2021

The purification of tissue inhibitor of metalloproteinases-2 from its 72 kDa progelatinase complex. Demonstration of the biochemical similarities of tissue inhibitor of metalloproteinases-2 and tissue inhibitor of metalloproteinases-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2898%2900046-0

7 January 2021

Quantitation of matrix metalloproteinases in cultured rat astrocytes using the polymerase chain reaction with a multi-competitor cDNA standard.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2898%2900046-0

7 January 2021

10.1016/S0165-5728(98)00046-0

Identifiers

DOI

1 reference

16 August 2017

1 reference